Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Actavis (ACT)

Add to Watchlists
Create an Alert
201.37 -2.14  -1.05% NYSE Apr 24, 10:54AM BATS Real time Currency in USD
View Full Chart
ACT Price Chart
View All Events

ACT Events

Date Type Description
Apr 30 Misc Actavis PLC Q1 2014 Earnings Conference Call
Apr 30 Earnings Actavis PLC Q1 2014 Earnings Results. Estimate: 3.29.
Apr 01 Misc Actavis Acquires Silom Medical Company
Feb 20 Misc Actavis PLC Q4 2013 Earning Conference Call
Feb 20 Earnings Actavis PLC Q4 2013 Earning Result. Estimate: 3.06.
Jan 31 Misc Actavis Analyst Day
Oct 29 Misc Actavis, Inc. To Host Third Quarter 2013 Earnings Conference Call and Webcast
Oct 29 Earnings Q3 2013 Earnings. Estimate: 2.09.
Oct 01 Misc Actavis Completes Warner Chilcott Acquisition
Sep 27 Misc Actavis and Warner Chilcott Receive u.s. Ftc Clearance for Actavis' Proposed Acquisition of Warner Chilcott
View All Performance Charts

ACT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Actavis is up 103.9% over the last year vs S&P 500 Total Return up 21.33%, Teva Pharmaceutical up 35.91%, and Mylan up 77.01%.

Get Quote for

PDF Report for ACT

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ACT Pro Report PDF
Advertisement

Portfolio Strategies Featuring ACT

Did Actavis make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ACT Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: Ireland
  • Headquarters State/Province: N/A
  • Incorporation Country: Ireland
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013

Actavis PLC specialty pharmaceutical company engaged in developing, manufacturing and distributing generic, brand and biosimilar products.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ACT 201.37 -2.14 -1.05% 35.08B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.